Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Samaras

 

Group Leader
Associate Professor Katherine Samaras

 

We are particularly interested in the outcomes of bariatric surgery (gastric bypass) for severly overweight patients.

 



 

 

See also:

Campbell Research Group

Chisholm Research Group

Greenfield Research Group

News

 

Why a common HIV drug increases risk of heart attack

MEDIA RELEASE: 28 Jul 2010
Clinical researchers at Garvan and St. Vincent's Hospital have for the first time shown why a commonly used type of HIV drug is associated with a higher risk of heart attack.
 
 

The remarkable effects of fat loss on the immune system

MEDIA RELEASE: 20 Apr 2010
Garvan scientists have shown for the first time that even modest weight loss reverses many of the damaging changes often seen in the immune cells of obese people, particularly those with Type 2 diabetes.
 
 

Why HIV treatment makes people so susceptible to heart disease and diabetes

MEDIA RELEASE: 17 Nov 2008
Clinicians have known for some time that people treated for HIV also become much more susceptible to diabetes and heart disease. A study by scientists at Sydney’s Garvan Institute of Medical Research has now shown some of the reasons why – enabling better patient management and monitoring.
 
 

Personal tools